Ignite Creation Date:
2024-05-06 @ 1:39 PM
Last Modification Date:
2024-10-26 @ 1:18 PM
Study NCT ID:
NCT04088682
Status:
RECRUITING
Last Update Posted:
2019-10-09
First Post:
2019-09-09
Brief Title:
Clinical Performance and Quality Measures for Adults With Acute ST-Elevation Myocardial Infarction in China
Sponsor:
China National Center for Cardiovascular Diseases
Organization:
China National Center for Cardiovascular Diseases
Study Overview
Official Title:
Clinical Performance and Quality Measures for Adults With Acute ST-Elevation Myocardial Infarction in China
Status:
RECRUITING
Status Verified Date:
2019-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to investigate and evaluate clinical performance and quality measures for adults with acute ST-elevation myocardial infarction STEMI in China Further more the investigates like to develop quality improvement strategies and relevant tools focusing on treatment and clinical outcome in patients with STEMI This is a annually survey through consecutively recruiting all eligible inpatients and collecting relevant medical information the performance of all participating hospitals Further quality improvement strategies including summary of clinical performance and quality measures clinical pathways and team building will be organized for the purpose of quality improvement All hospitals will consecutively recruit qualified patients in the same method adopted in baseline period Then the reperfusion rates and other performance measures will be compared annually
Detailed Description:
Cardiovascular disease CVD is a major concern in public health globally as well as in China and remarkable variations of resources available and health system performance have been noted Acute myocardial infarction is one of the leading causes of mortality and morbidity both in rural and urban area
This study aims to investigate and evaluate clinical performance and quality measures for adults with acute ST-elevation myocardial infarction STEMI in China Further more the investigates like to develop quality improvement strategies and relevant tools focusing on treatment and clinical outcome in patients with STEMI
This is a annually survey through consecutively recruiting all eligible inpatients and collecting relevant medical information the performance of all participating hospitals Demographic characteristics clinical features diagnostic tests medications procedures and in-hospital outcomes of patients will be obtained and then the treatment pattern and outcomes will be evaluated Further quality improvement strategies including summary of clinical performance and quality measures clinical pathways and professional training will be organized for the purpose of quality improvement All hospitals will consecutively recruit qualified patients in the same method adopted in baseline period Then the reperfusion rates and other performance measures will be compared annually
New knowledge will be generated about STEMI management in China to improve STEMI patients prognosis in future
This study aims to investigate and evaluate clinical performance and quality measures for adults with acute ST-elevation myocardial infarction STEMI in China Further more the investigates like to develop quality improvement strategies and relevant tools focusing on treatment and clinical outcome in patients with STEMI
This is a annually survey through consecutively recruiting all eligible inpatients and collecting relevant medical information the performance of all participating hospitals Demographic characteristics clinical features diagnostic tests medications procedures and in-hospital outcomes of patients will be obtained and then the treatment pattern and outcomes will be evaluated Further quality improvement strategies including summary of clinical performance and quality measures clinical pathways and professional training will be organized for the purpose of quality improvement All hospitals will consecutively recruit qualified patients in the same method adopted in baseline period Then the reperfusion rates and other performance measures will be compared annually
New knowledge will be generated about STEMI management in China to improve STEMI patients prognosis in future
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None